This brand name is authorized in Estonia, Lithuania
The drug RALOXA contains one active pharmaceutical ingredient (API):
|
1
Raloxifene
UNII 4F86W47BR6 - RALOXIFENE HYDROCHLORIDE
|
|
As a selective oestrogen receptor modulator (SERM), raloxifene has selective agonist or antagonist activities on tissues responsive to oestrogen. It acts as an agonist on bone and partially on cholesterol metabolism (decrease in total and LDL-cholesterol), but not in the hypothalamus or in the uterine or breast tissues. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G03XC01 | Raloxifene | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03X Other sex hormones and modulators of the genital system → G03XC Selective estrogen receptor modulators |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1364363, 1365016, 1365038, 1365049, 1365050, 1365061, 1365072, 1365083, 1365094, 1365106, 1365117, 1365128, 1365139, 1365140, 1365151, 1365162, 1365173 |
| Country: LT | Valstybinฤ vaistลณ kontrolฤs tarnyba | Identifier(s): 1033356, 1064480, 1064481, 1064482, 1064483, 1064484, 1064485, 1064486, 1064487, 1064488, 1064489, 1064490, 1064491 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
